Published August 2011 | Version v1
Journal article

Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility

  • 1. Institute of Cancer Research and Royal Marsden, NHS Foundation Trust, MRI Department, Surrey (United Kingdom)
  • 2. Institute of Cancer Research and Royal Marsden, NHS Foundation Trust, Cancer Research UK Clinical Magnetic Resonance Research Group, Surrey (United Kingdom)

Description

To establish normal bone marrow values of apparent diffusion coefficient (ADC) over an age range, compare them with metastatic and myelomatous involvement, to establish reproducibility and to optimise b values. The ADCs of bone marrow in 7 volunteers (mean age 29.7 years), 34 volunteers (mean age 63.3 years) and 43 patients with metastatic and myelomatous involvement (mean age 65.5 years) were measured. In 9 volunteers diffusion weighted MRI was repeated within 7 days. b values were derived to optimise contrast between normal and pathological marrow. The mean ADC of bone marrow in younger volunteers was significantly higher than that of older volunteers. The coefficient of reproducibility was 14.8%. The ADC mean of metastatic and myeloma bone disease was 1054+/-456 x 10-6 mm2s-1. An ADC threshold of 655 x 10-6 mm2s-1 separated normal and abnormal marrow with a sensitivity and specificity of 90% and 93% respectively. Contrast between normal and abnormal marrow was optimal at b = 1389 smm-2. The reproducibility of ADC measurements in bone is equivalent to published data for soft tissue with a high sensitivity and specificity for separating abnormal from age matched normal bone marrow. A b value of around 1,400 smm-2 is optimal for imaging bone marrow. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-011-2116-4

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
21
Journal Issue
8
Journal Page Range
p. 1713-1718
ISSN
0938-7994
CODEN
EURAE3